Isolated Soy Protein Promotes Mammary Tumor Development Induced by the Type I Insulin-like Growth Factor Receptor in Transgenic Mice

References

• Wu AH, Lee E, Vigen C. Soy isoflavones and breast cancer. Am Soc Clin Oncol Educ Book. 2013;33:102–106. doi:10.1200/EdBook_AM.2013.33.102
   Google Scholar
• Qin LQ, Xu JY, Wang PY, Hoshi K. Soyfood intake in the prevention of breast cancer risk in women: a meta-analysis of observational epidemiological studies. J Nutr Sci Vitaminol. 2006;52(6):428–436. doi:10.3177/jnsv.52.428
   PubMed Web of Science ®Google Scholar
• Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst. 2006;98(7):459–471. doi:10.1093/jnci/djj102
   PubMed Web of Science ®Google Scholar
• Enderlin CA, Coleman EA, Stewart CB, Hakkak R. Hakkak R: Dietary soy intake and breast cancer risk. Oncol Nurs Forum. 2009;36(5):531–539. doi:10.1188/09.ONF.531-539
   PubMed Web of Science ®Google Scholar
• Dong JY, Qin LQ. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat. 2011;125(2):315–323. doi:10.1007/s10549-010-1270-8
   PubMed Web of Science ®Google Scholar
• Messina M, Wu AH. Perspectives on the soy-breast cancer relation. Am J Clin Nutr. 2009;89(5):1673S–1679S. doi:10.3945/ajcn.2009.26736V
   PubMed Web of Science ®Google Scholar
• Murkies AL, Wilcox G, Davis SR. Clinical review 92: phytoestrogens. J Clin Endocrinol Metab. 1998;83(2):297–303. doi:10.1210/jcem.83.2.4577
   PubMed Web of Science ®Google Scholar
• Price KR, Fenwick GR. Naturally occurring oestrogens in foods-a review. Food Addit Contam. 1985;2(2):73–106. doi:10.1080/02652038509373531
   PubMed Web of Science ®Google Scholar
• Vitale DC, Piazza C, Melilli B, Drago F, Salomone S. Isoflavones: estrogenic activity, biological effect and bioavailability. Eur J Drug Metab Pharmacokinet. 2013;38(1):15–25. doi:10.1007/s13318-012-0112-y
   PubMed Web of Science ®Google Scholar
• Lippman ME, Krueger KA, Eckert S, Sashegyi A, Walls EL, Jamal S, Cauley JA, Cummings SR. Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants. JCO. 2001;19(12):3111–3116. doi:10.1200/JCO.2001.19.12.3111
   PubMed Web of Science ®Google Scholar
• Rowlands JC, Berhow MA, Badger TM. Estrogenic and antiproliferative properties of soy sapogenols in human breast cancer cells in vitro. Food Chem Toxicol. 2002;40(12):1767–1774. doi:10.1016/s0278-6915(02)00181-3
   PubMed Web of Science ®Google Scholar
• Hsieh CC, Hernandez-Ledesma B, Jeong HJ, Park JH, de Lumen BO. Complementary roles in cancer prevention: protease inhibitor makes the cancer preventive peptide lunasin bioavailable. PLoS One. 2010;5(1):e8890. doi:10.1371/journal.pone.0008890
   PubMed Web of Science ®Google Scholar
• Chatterjee C, Gleddie S, Xiao CW. Soybean bioactive peptides and their functional properties. Nutrients. 2018;10(9):1211. doi:10.3390/nu1009
   PubMed Web of Science ®Google Scholar
• Barnes S. The biochemistry, chemistry and physiology of the isoflavones in soybeans and their food products. Lymphat Res Biol. 2010;8(1):89–98. doi:10.1089/lrb.2009.0030
   PubMed Web of Science ®Google Scholar
• Setchell KD, Cole SJ. Variations in isoflavone levels in soy foods and soy protein isolates and issues related to isoflavone databases and food labeling. J Agric Food Chem. 2003;51(14):4146–4155. doi:10.1021/jf026199b
   PubMed Web of Science ®Google Scholar
• Fang N, Yu S, Badger TM. Comprehensive phytochemical profile of soy protein isolate. J Agric Food Chem. 2004;52(12):4012–4020. doi:10.1021/jf049842y
   PubMed Web of Science ®Google Scholar
• Moorehead RA. Rodent models assessing mammary tumor prevention by Soy or Soy Isoflavones. Genes (Basel). 2019;10:566. doi:10.3390/genes10080
   PubMed Web of Science ®Google Scholar
• Watson KL, Stalker L, Jones RA, Moorehead RA. High levels of dietary soy decrease mammary tumor latency and increase incidence in MTB-IGFIR transgenic mice. BMC Cancer. 2015;15:37. doi:10.1186/s12885-015-1037-z
   PubMed Web of Science ®Google Scholar
• Jones RA, Campbell CI, Gunther EJ, Chodosh LA, Petrik JJ, Khokha R, Moorehead RA. Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation. Oncogene. 2007;26(11):1636–1644. doi:10.1038/sj.onc.1209955
   PubMed Web of Science ®Google Scholar
• Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671–675. doi:10.1038/nmeth.2089
   PubMed Web of Science ®Google Scholar
• Watson KL, Moorehead RA. Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice. BMC Cancer. 2013;13:375. doi:10.1186/1471-2407-13-375
   PubMed Web of Science ®Google Scholar
• Jones R, Watson K, Bruce A, Nersesian S, Kitz J, Moorehead R. Re-expression of miR-200c suppresses proliferation, colony formation and in vivo tumor growth of murine claudin-low mammary tumor cells. Oncotarget. 2017;8(14):23727–23749. doi:10.18632/oncotarget.15829
   PubMedGoogle Scholar
• Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma'ayan A. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 2013;14:128. doi:10.1186/1471-2105-14-128
   PubMed Web of Science ®Google Scholar
• Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, Koplev S, Jenkins SL, Jagodnik KM, Lachmann A, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90–W97. doi:10.1093/nar/gkw377
   PubMed Web of Science ®Google Scholar
• Schedin P, Keely PJ. Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harb Perspect Biol. 2011;3(1):a003228. doi:10.1101/cshperspect.a003228
   PubMed Web of Science ®Google Scholar
• Lv Y, Chen C, Zhao B, Zhang X. Regulation of matrix stiffness on the epithelial-mesenchymal transition of breast cancer cells under hypoxia environment. Naturwissenschaften. 2017;104(5–6):38. doi:10.1007/s00114-017-1461-9
   PubMed Web of Science ®Google Scholar
• Boyd NF, Li Q, Melnichouk O, Huszti E, Martin LJ, Gunasekara A, Mawdsley G, Yaffe MJ, Minkin S. Evidence that breast tissue stiffness is associated with risk of breast cancer. PLoS One. 2014;9(7):e100937. doi:10.1371/journal.pone.0100937
   PubMed Web of Science ®Google Scholar
• Mokbel K, Mokbel K. Chemoprevention of breast cancer with vitamins and micronutrients: a concise review. In Vivo. 2019;33(4):983–997. doi:10.21873/invivo.11568
   PubMed Web of Science ®Google Scholar
• Yu L, Tan Y, Zhu L. Dietary vitamin B2 intake and breast cancer risk: a systematic review and meta-analysis. Arch Gynecol Obstet. 2017;295(3):721–729. doi:10.1007/s00404-016-4278-4
   PubMed Web of Science ®Google Scholar
• Chen P, Li C, Li X, Li J, Chu R, Wang H. Higher dietary folate intake reduces the breast cancer risk: a systematic review and meta-analysis. Br J Cancer. 2014;110(9):2327–2338. doi:10.1038/bjc.2014.155
   PubMed Web of Science ®Google Scholar
• Mullie P, Koechlin A, Boniol M, Autier P, Boyle P. Relation between breast cancer and high glycemic index or glycemic load: a meta-analysis of prospective cohort studies. Crit Rev Food Sci Nutr. 2016;56(1):152–159. doi:10.1080/10408398.2012.718723
   PubMed Web of Science ®Google Scholar
• Choi Y, Giovannucci E, Lee JE. Glycaemic index and glycaemic load in relation to risk of diabetes-related cancers: a meta-analysis. Br J Nutr. 2012;108(11):1934–1947. doi:10.1017/S0007114512003984
   PubMed Web of Science ®Google Scholar
• Dong JY, Zhang L, Zhang YH, Qin LQ. Dietary glycaemic index and glycaemic load in relation to the risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Br J Nutr. 2011;106(11):1649–1654. doi:10.1017/S000711451100540X
   PubMed Web of Science ®Google Scholar
• de Beer JC, Liebenberg L. Does cancer risk increase with HbA1c, independent of diabetes? Br J Cancer. 2014;110(9):2361–2368. doi:10.1038/bjc.2014.150
   PubMed Web of Science ®Google Scholar
• Thompson HJ, Neuhouser ML, Lampe JW, McGinley JN, Neil ES, Schwartz Y, McTiernan A. Effect of low or high glycemic load diets on experimentally induced mammary carcinogenesis in rats. Mol Nutr Food Res. 2016;60(6):1416–1426. doi:10.1002/mnfr.201500864
   PubMed Web of Science ®Google Scholar
• Bojkova B, Kajo K, Garajova M, Kubatka P, Pec M, Kiskova T, Orendas P, Kassayova M, Korpova M, Miklosova M, et al. Rosiglitazone shows partial oncostatic effect in rat mammary carcinogenesis. Neoplasma. 2013;60(1):46–55.:doi:10.4149/neo_2013_007
   PubMed Web of Science ®Google Scholar
• Wellberg EA, Johnson S, Finlay-Schultz J, Lewis AS, Terrell KL, Sartorius CA, Abel ED, Muller WJ, Anderson SM. The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis. Breast Cancer Res. 2016;18(1):131. doi:10.1186/s13058-016-0795-0
   PubMed Web of Science ®Google Scholar
• Peiroten A, Bravo D, Landete JM. Bacterial metabolism as responsible of beneficial effects of phytoestrogens on human health. Crit Rev Food Sci Nutr. 2020;60(11):1922–1937. doi:10.1080/10408398.2019.1622505
   PubMed Web of Science ®Google Scholar
• Sonnenburg ED, Sonnenburg JL. Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metab. 2014;20(5):779–786. doi:10.1016/j.cmet.2014.07.003
   PubMed Web of Science ®Google Scholar
• Eswaran S, Muir J, Chey WD. Fiber and functional gastrointestinal disorders. Am J Gastroenterol. 2013;108(5):718–727. doi:10.1038/ajg.2013.63
   PubMed Web of Science ®Google Scholar
• Forgie AJ, Fouhse JM, Willing BP. Diet-microbe-host interactions that affect gut mucosal integrity and infection resistance. Front Immunol. 2019;10:1802. doi:10.3389/fimmu.2019.01802
   PubMed Web of Science ®Google Scholar